-
Mashup Score: 0Brian Hilberdink and Douglas Maslin on LEO Pharma | AMCP.org - 3 day(s) ago
Host Fred Goldstein invites Brian Hilberdink, President, Executive Vice President North America and Douglas Maslin, MD, Global Principal Medical Advisor to discuss LEO Pharma and their involvement with AMCP.
Source: amcp.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Thousands of Managed Care Professionals Address Complex Issues at AMCP Nexus 2024 | AMCP.org - 4 day(s) ago
More than 2,500 managed care pharmacy professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Las Vegas, NV from Oct. 14–17 for AMCP Nexus 2024, the industry’s premier fall meeting. Attendees connected with like-minded professionals, discussed the key trends impacting their work, and expanded their perspectives through leading-edge education sessions.
Source: amcp.orgCategories: General Medicine News, PayerTweet-
It is essential to convene stakeholders from various fields and create a space for meaningful dialogue. #AMCPNexus2024 was the latest forum for this exchange among managed care pharmacy leaders. Our latest blog captured the highlights – read here https://t.co/uDPW7e0Ply https://t.co/bFY5HZM6JC
-
-
Mashup Score: 0
Explore the 2024 presidential election’s impact on health care policy under President Trump and the 119th Congress.
Source: www.amcp.orgCategories: General Medicine News, PayerTweet-
Explore the 2024 presidential election's impact on #healthcare policy under President-elect Trump and the 119th Congress with this exclusive presentation. Dive into key issues, including PBM and 340B reform, the Inflation Reduction Act, and more: https://t.co/ACe5cGVQSh #ira
-
-
Mashup Score: 0
IGBA will be hosting the 5th annual Global Biosimilars Week from 11-15 November 2024. This social media campaign aims to raise awareness of the powerful impact of biosimilar medicines.
Source: www.globalbiosimilarsweek.orgCategories: General Medicine News, PayerTweet-
As #GlobalBiosimilarWeek comes to a close, hear from AMCP's Chief Science Officer & Executive Director of #BBCIC, Cate Lockhart about what AMCP is doing to participate in the development of #biosimilars across the world. Learn more: https://t.co/nGeJPU3ZAu https://t.co/yP7bHDnnBz
-
-
Mashup Score: 0Publications and Presentations | BBCIC - 8 day(s) ago
Check out BBCIC’s peer-reviewed publications, presentations and abstracts.
Source: www.bbcic.orgCategories: General Medicine News, PayerTweet-
Before a #biosimilar hits the market, scientists test everything to ensure it’s a match for the original. BBCIC's scientists develop proposals related to biosimilars. Even Ivan takes his work seriously! https://t.co/qJW5X7V7aL #Testing #Trust #GlobalBiosimilarsWeek https://t.co/DzrK5tmD8v
-
-
Mashup Score: 2BBCIC: Transparency of Its Science-Driven Approach | BBCIC - 9 day(s) ago
BBCIC statement on Transparency of its science-driven approach
Source: www.bbcic.orgCategories: General Medicine News, PayerTweet-
Biosimilars go through rigorous training to show they can work just as well as the originals. Sometimes in their rigorous training, a pup is trained to sniff things out for a safe walk down the block. https://t.co/kAL1apJL60 #EquivalentStrength #GlobalBiosimilarsWeek #biosimilars https://t.co/M57D13p3qj
-
-
Mashup Score: 0Panel 2: Post Election: What’s Changed and What Endures? | Alliance for Health Policy - 12 day(s) ago
This panel will explore the evolving health care landscape in the wake of the election and its impact on the policy community. Experts from across the health care industry will provide insights into what the health policy community can expect from the new administration and Congress. What key issues will remain central? What shifts in […]
Source: www.allhealthpolicy.orgCategories: General Medicine News, PayerTweet-
The U.S. election is over… now what? AMCP’s Adam Colborn and leaders from @ADVIhealth and @commonwealthfnd will share what to expect within the health policy landscape at the @AllHealthPolicy Post-Election Symposium on 11/13. Check it out: https://t.co/KNg0i5Wkgl https://t.co/1ZIkig3CEw
-
-
Mashup Score: 0
As the United States approaches the 2024 presidential election, health care remains a pivotal issue for Americans. This symposium will provide an opportunity for us to learn from the outcomes of the election and campaign season about the state of health care and what can be expected in the future. Panel presentations and keynote speakers […]
Source: www.allhealthpolicy.orgCategories: General Medicine News, PayerTweet-
Following the elections, @AllHealthPolicy will be convening health care professionals for a Post-Election Symposium on 11/13 to discuss the latest election results and the current and future state of the industry. Learn more: https://t.co/WiUh5S5ZVi
-
-
Mashup Score: 1
Get quick answers to some of the most common questions on GLP-1 therapies. Get quick answers to some of the most common questions on GLP-1 therapies. Explore how these treatments fit into managed care pharmacy and the nuances of managing this class.
Source: www.amcp.orgCategories: General Medicine News, PayerTweet-
Explore the impact of GLP-1 therapies on obesity & weight loss through AMCP's FAQs to uncover the latest developments, their use in weight management drugs, and patient benefits. #GLP1 #WeightLossInnovation #HealthCareUpdates. https://t.co/5Fhwk02xaZ https://t.co/91UOlMdBq3
-
-
Mashup Score: 1Prescription Digital Therapeutics | AMCP.org - 18 day(s) ago
AMCP supports increased access to Prescription Digital Therapeutics (PDTs). PDTs are software-based therapies that deliver clinical benefits to patients, either alone or in combination with other forms of treatment. These therapeutics require a prescription and are subject to oversight by the Food and Drug Administration (FDA). To be approved by the FDA, PDTs must demonstrate both safety and efficacy.
Source: www.amcp.orgCategories: General Medicine News, PayerTweet-
Patient-centric solutions are vital to closing health care gaps & @CMSGov’s coverage of digital mental health treatment devices is a significant step in opening access to these life-changing therapies. There’s more work to be done, but for now, read more: https://t.co/ASGtuFMDuK
-
In AMCP's latest podcast, host Fred Goldstein invites Brian Hilberdink & Douglas Maslin to discuss @LEOHealthySkin and their involvement with AMCP. Listen now: https://t.co/83XqWL4HIE #AMCPListenUp https://t.co/B5KXGhePuo